Ingredient | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Tretinoin |
C
|
|
||||||
Tartaric Acid |
C
|
|
||||||
Azelaic Acid |
C
|
|
||||||
Salicylic Acid |
C
|
|
||||||
Metronidazole |
C
|
|
Product | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Imedeen |
C
|
|
||||||
Vivida |
C
|
|
||||||
Olay Total Effects 7X Visible Anti-Aging Vitamin Complex + Tretinoin |
C
|
|
||||||
Retin-A |
C
|
|
||||||
MetroGel |
C
|
|
Skincare treatments can penetrate more deeply into the skin to provide faster, more dramatic and longer-lasting results than topical products, but they are also much more expensive.
Review all of the scientific evidence before spending thousands of dollars on treatments that won't work, or that make your skin worse due to the side effects.
Log in to register your interest in knowing when information on skincare treatments becomes available on Wisderm.com, and get a 20% discount on launch!
Intervention | Tretinoin |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 299 |
Intervention | Tretinoin |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Non-Randomised Controlled |
Trial Duration | 308 days |
Participants | 355 |
Intervention | Tretinoin |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 112 days |
Participants | 40 |
Intervention | Tretinoin |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 1640 |
Intervention | Tretinoin |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 381 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 67 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 381 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 155 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 116 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Open-Label Randomised Controlled |
Trial Duration | 56 days |
Participants | 30 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 664 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 105 days |
Participants | 251 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Randomised Controlled |
Trial Duration | 56 days |
Participants | 85 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 112 days |
Participants | 20 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 52 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 105 days |
Participants | 40 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 112 days |
Participants | 401 |
Intervention | Azelaic Acid |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 221 |
Intervention | Metronidazole |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 105 days |
Participants | 251 |
Intervention | Gluconolactone |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 28 days |
Participants | 11 |
Intervention | Niacinamide |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 52 |
Intervention | Niacinamide |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 294 days |
Participants | 79 |
Intervention | Niacinamide |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 56 days |
Participants | 30 |
Intervention | Niacinamide |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Single-Blind Non-Randomised Controlled |
Trial Duration | 56 days |
Participants | 28 |
Intervention | Niacinamide |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 50 |
Intervention | Niacinamide |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Randomised Controlled |
Trial Duration | 28 days |
Participants | 20 |
Intervention | Adapalene |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 653 |
Intervention | Adapalene |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Randomised Controlled |
Trial Duration | 56 days |
Participants | 85 |
Intervention | Adapalene |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Trial Duration | 252 days |
Participants | 90 |
Intervention | Hydroquinone |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Randomised Controlled |
Trial Duration | 28 days |
Participants | 44 |
Intervention | Hydroquinone |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 80 |
Intervention | Hydroquinone |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 112 days |
Participants | 20 |
Intervention | Hydroquinone |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 155 |
Intervention | Hydroquinone |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Open-Label Randomised Controlled |
Trial Duration | 56 days |
Participants | 30 |
Intervention | Hydroquinone |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Trial Duration | 120 days |
Participants | 40 |
Intervention | Kinetin |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 84 days |
Participants | 18 |
Intervention | Galactomyces Ferment Filtrate |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 42 days |
Participants | 20 |
Intervention | Finacea |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 67 |
Intervention | Finacea |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 105 days |
Participants | 251 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Kinerase |
---|---|
Concern | Skin Redness |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 84 days |
Participants | 18 |